JOGO Health Pvt Ltd is a US based digital therapeutic company that created the JOGO (device). JOGO is a patented AI-driven wearable sensor that applies the science of EMG Biofeedback facilitating neuroplasticity. JOGO is a non-invasive, portable, wireless digital device that is 510K exempted by the US FDA. It treats various pelvic floor disorders (urinary & fecal incontinence, pelvic organ prolapse, chronic constipation & voiding dysfunction) along with other conditions such as post-stroke spasticity, Parkinson’s tremors, migraine and chronic low back pain.
CEO Sanjai Murali of JOGO Health stated, ” This collaboration with AINU reflects our shared vision of developing innovative and patient-first solutions for urological conditions.”
“By adopting JOGO therapy, we will provide our patients with an advanced technology that offers effective patient recovery ” stated Dr. Arunkumar Balakrishnan, Managing Director & Chief Consultant Urologist, AINU
This inauguration was presided by Dr. Arunkumar Balakrishnan, Dr. D. Venkat Subramaniam (Executive Director & Sr. Consultant Urologist), Dr. Mathisekaran Thangarasu (Consultant Urologist) & Dr. Sanjay Prakash J (Consultant Andrologist & Urologist).
JOGO has clinical research partnerships with world-renowned institutions like Mayo Clinic & Harvard Medical School. JOGO is also accredited by J&J Innovation Labs. JOGO Clinic, Chennai is world’s 1st JCI Accredited Comprehensive Rehab Centre.
JOGO has treated 15,000+ patients & has clinical partnerships with 50+ leading hospitals in India. JOGO serves Mumbai, Delhi, Chennai, Bengaluru, Kolkata, Madurai, Coimbatore, and Trivandrum in India. The company has operations in the US, Canada, India, and Malaysia, and is set to expand into the UAE (Abu Dhabi & Dubai), Europe, and South Asia soon.
Charles Jesudasan, GM, JOGO Health said , “The collaboration of AINU, a centre of excellence for Nephrology & Urology with JOGO Health Pvt Ltd promises a new era of Digital therapy that is set to revolutionize the rehab sector”
